Disease & disorder

bone neoplasm

MONDO:0019060

A benign, intermediate, or malignant neoplasm involving the bone or articular cartilage.

Clinical trials13
Recruiting1
Drug concepts studied3
Synonyms24

Research intelligence

Directly mapped studies only · unique clinical trials

Current registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.

Medications under investigation

Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.

Loading mapped interventions…

MONDO disease family

Loading verified ontology relationships…

Recruiting studies by city

Loading research-site locations…

Trial status

Loading…

Trial phase

Loading…

Study start year

Loading…

Investigated drug interventions

Loading…
Background context

Bone tumor

A bone tumor is an abnormal growth of tissue in bone. Cancerous bone tumors usually originate from a cancer in another part of the body such as from lung, breast, thyroid, kidney and prostate. There may be a lump, pain, or neurological signs from pressure. A bone tumor might present with a pathologic fracture. Other symptoms may include fatigue, fever, weight loss, anemia and nausea. Sometimes there are no symptoms and the tumor is found when investigating another problem. Diagnosis is generally by X-ray and other radiological tests such as CT scan, MRI, PET scan and bone scintigraphy. Blood tests might include a complete blood count, inflammatory markers, serum electrophoresis, PSA, kidney function and liver function. Urine may be tested for Bence Jones protein. For confirmation of diagnosis, a biopsy for histological evaluation might be required. The most common bone tumor is a non-ossifying fibroma. Average five-year survival in the United States after being diagnosed with bone and joint cancer is 68%. The earliest known bone tumor was an osteosarcoma in a foot bone discovered in South Africa, between 1.6 and 1.8 million years ago.

Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.

Clinical trials

13 shown
Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image GuidanceNCT07636148 · 2026-07-01
RECRUITING
A Dose Finding Study to Treat Bone Tumor(s)NCT06008483 · 2022-04-05
TERMINATED
Early Recovery After "Wedge Resection" Surgery to Remove Lung Mestastasis Secondary to Bone Cancer.NCT05310539 · 2022-01-08
COMPLETED
Retrospective Case Series of COVID19+ Patients Undergoing Orthopedic SurgeryNCT05881343 · 2020-07-18
COMPLETED
9-ING-41 in Patients With Advanced CancersNCT03678883 · 2019-01-04
ACTIVE_NOT_RECRUITING
The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After ChemotherapyNCT02905916 · 2016-06-01
UNKNOWN
Pilot Study of Stereotactic Ablation for Oligometastatic Breast Neoplasia in Combination With the Anti-PD-1 Antibody MK-3475NCT02303366 · 2015-09-01
COMPLETED
Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic AcidNCT02274623 · 2014-12-01
COMPLETED
Preliminary Study of Microwave Tumoral Ablation Performances for the Treatment of Pulmonary, Renal and Bone Neoplasia.NCT02862288 · 2012-09-01
COMPLETED
Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone DiseaseNCT00558272 · 2008-02-01
COMPLETED
A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease.NCT00478270 · 2007-06-01
WITHDRAWN
Bonefos and the Consumption of AnalgesicsNCT00909142 · 2007-04-01
COMPLETED
Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone MetastasesNCT00434447 · 2006-12-01
COMPLETED

Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.